Jiangsu Nhwa Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Jiangsu Nhwa Pharmaceutical has a total shareholder equity of CN¥6.7B and total debt of CN¥85.2M, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are CN¥7.6B and CN¥928.1M respectively. Jiangsu Nhwa Pharmaceutical's EBIT is CN¥1.2B making its interest coverage ratio -16.5. It has cash and short-term investments of CN¥3.5B.
Key information
1.3%
Debt to equity ratio
CN¥85.23m
Debt
| Interest coverage ratio | -16.5x |
| Cash | CN¥3.52b |
| Equity | CN¥6.71b |
| Total liabilities | CN¥928.14m |
| Total assets | CN¥7.64b |
Recent financial health updates
Recent updates
The Market Doesn't Like What It Sees From Jiangsu Nhwa Pharmaceutical Co., LTD's (SZSE:002262) Earnings Yet
Sep 04
Here's Why Jiangsu Nhwa Pharmaceutical (SZSE:002262) Has Caught The Eye Of Investors
Jul 22Jiangsu Nhwa Pharmaceutical (SZSE:002262) Seems To Use Debt Rather Sparingly
Jun 16Jiangsu Nhwa Pharmaceutical Co., LTD's (SZSE:002262) Share Price Is Matching Sentiment Around Its Earnings
May 09Jiangsu Nhwa Pharmaceutical (SZSE:002262) Ticks All The Boxes When It Comes To Earnings Growth
Apr 18Earnings Update: Jiangsu Nhwa Pharmaceutical Co., LTD (SZSE:002262) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Apr 02Financial Position Analysis
Short Term Liabilities: 002262's short term assets (CN¥5.5B) exceed its short term liabilities (CN¥828.7M).
Long Term Liabilities: 002262's short term assets (CN¥5.5B) exceed its long term liabilities (CN¥99.4M).
Debt to Equity History and Analysis
Debt Level: 002262 has more cash than its total debt.
Reducing Debt: 002262's debt to equity ratio has reduced from 11.4% to 1.3% over the past 5 years.
Debt Coverage: 002262's debt is well covered by operating cash flow (1389.6%).
Interest Coverage: 002262 earns more interest than it pays, so coverage of interest payments is not a concern.